Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 274 Breast Neoplasms 263 Lung Neoplasms 135 Prostatic Neoplasms 115 Colorectal Neoplasms 107 Carcinoma, Non-Small-Cell Lung 103 Pancreatic Neoplasms 70 Carcinoma, Hepatocellular 55 Ovarian Neoplasms 51 Multiple Myeloma 50 Hematologic Neoplasms 50 Urinary Bladder Neoplasms 49 Stomach Neoplasms 49 Brain Neoplasms 48 Melanoma 44 Leukemia, Myeloid, Acute 43 Head and Neck Neoplasms 43 Esophageal Neoplasms 41 Disease 38 Rectal Neoplasms 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 36 Liver Neoplasms 36 Colonic Neoplasms 35 Lymphoma 34 Neoplasm Metastasis 33 Leukemia, Lymphocytic, Chronic, B-Cell 31 Endometrial Neoplasms 30 Kidney Neoplasms 29 Carcinoma, Renal Cell 29 Recurrence 28

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hormone Receptor Positive Breast Cancer × 90 days × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡